MedTrace Logo

Dexamethasone With Ropivacaine for PENG Block in Total Hip Arthroplasty

NCT06470334 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-07-11

No results posted yet for this study

Summary

Does adding Dexamethasone to the Periarticular Nerve Group Block in Patients undergoing Total Hip Arthroplasty reduce the dose of ropivacaine?

Conditions

  • Hip Osteoarthritis
  • Hip Pain Chronic
  • Hip Arthritis

Interventions

DRUG

Ropivacaine

Ultrasound-guided PENG block - 20ml 0,2% ropivacaine

DRUG

Ropivacaine+Dexamethasone

Ultrasound-guided PENG block - 10ml 0,2% ropivacaine + 4mg Dexamethasone

Sponsors & Collaborators

  • Poznan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Malgorzata Reysner, M.D. Ph.D. · Poznań University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-07
Primary Completion
2025-03-31
Completion
2025-04-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06470334 on ClinicalTrials.gov